Composition of Cassia fistula oil and its antifungal activity by disrupting ergosterol biosynthesis

Natural Product Communications

Volumn 8, Issue 2, 2013, Pages 261-264

  Irshad, Md ^a,b,c   Ahmad, Aijaz ^a   Zafaryab, Md ^a   Ahmad, Farah ^c   Manzoor, Nikhat ^a   Singh, Man ^b   Rizvi, M Moshahid A ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b CENTRAL UNIVERSITY OF GUJARAT   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anticandidal; Cassia fistula; Ergosterol inhibition

Indexed keywords

ALPHA AMYRIN; AMPHOTERICIN B; BETULIC ACID; CASSIA FISTULA EXTRACT; ERGOSTEROL; FLUCONAZOLE; FRIEDELIN; FUCOSTEROL; HEMOGLOBIN; LUPEOL; SITOSTEROL; STIGMASTEROL;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CASSIA FISTULA; CHEMICAL COMPOSITION; CONTROLLED STUDY; FUNGAL CELL WALL; HEMOLYSIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MASS FRAGMENTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT SEED; STEROL SYNTHESIS;

EID: 84875798898     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1300800233     Document Type: Article

References (32)

1. (a) Shao PL, Huang LM, Hsueh PR. (2007) Recent advances and challenges in the treatment of invasive fungal infections. International Journal of Antimicrobial Agents, 30, 487-95;
2. (b) Ahmad A, Khan A, Manzoor N, Khan LA. (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microbial Pathogenesis, 48, 35-41;
3. (c) Lupetti A, Danesi R, Campa M, Del-Tacca M, Kelly S. (2002) Molecular basis of resistance to azole antifungals. Trends in Molecular Medicine, 8, 76-81;
4. (d) Khan A, Ahmad A, Manzoor N, Khan LA. (2010) Antifungal activities of Ocimum sanctum essential oil and its lead molecules. Natural Product Communications, 5, 345-349.
5. (a) Moshahid AR, Irshad M, Gamal EH, Salaem BY. (2009) Bioefficacies of Cassia fistula: An Indian labrum. African Journal of Pharmacy and Pharmacology, 3, 287-292;
6. (b) Irshad M, Singh M, Rizvi MMA.(2010) Assessment of anthelmintic activity of Cassia fistula L. Middle-East Journal of Scientific Research, 5, 346-349;
7. (c) Akanmu MA, Iwalewa EO, Lujoba AA, Adelusola KA.(1994) Toxicity potentials of Cassia fistula fruits as laxative with reference to Senna. African Journal of Biomedical Research, 7, 23-26;
8. (d) Irshad M, Singh M, Zafaryab M, Rizvi MMA. (2012) Comparative analysis of the antioxidant activity of Cassia fistula extracts. International Journal of Medicinal Chemistry, doi:10.1155/2012/157125.
9. Irshad M, Shreaz S, Manzoor N, Khan LA, Rizvi MMA. (2011) Anticandidal activity of Cassia fistula and its effect on ergosterol biosynthesis. Pharmaceutical Biology, 49, 727-733.
10. (a) Ling WH, Jones PJH. (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Science, 57, 195-206;
11. (b) Yasukawa K, Takido M, Matsumoto T, Takeuchi M, Nakagawa S. (1991) Sterol and triterpene derivatives from plants inhibit the effects of tumour promoter and sitosterol and betulinic acid inhibit tumour formation in mouse skin two stage carcinogenesis. Oncology, 41, 72-76;
12. (c) Raicht R, Cohen B, Fazzini E. (1980) Protective effect of plant sterols against chemically induced colon tumours in rats. Cancer Research, 40, 403-405.
13. Gupta R, Sharma AK, Dobhal MP, Sharma MC, Gupta RS. (2011) Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemia. Journal of Diabetes, 3, 29-37.
14. Mbambo B, Odhav B, Mohanlall V. (2012) Antifungal activity of stigmasterol, sitosterol and ergosterol from Bulbine natalensis Baker (Asphodelaceae). Journal of Medicinal Plants Research, DOI: 10.5897/JMPR12.151
15. (a) Atta-Ur-Rahman, Choudhary MI, Majeed A, Shabbir M, Ghani U, Shameel M. (1997) A succinylanthranilic acid ester and other bioactive constituents of Jolyna laminarioides. Phytochemistry, 46, 1215-1218;
16. (b) Lee YS, Shin KH, Kim BK, Lee S. (2004) Anti-diabetic activities of fucosterol from Pelvetia siliquosa. Archives of Pharmacal Research, 27, 1120-1122.
17. (a) Zheng Y, Huang W, Yoo J, Ebersole JL, Huang CB. (2011) Antibacterial compounds from Siraitia grosvenorii leaves. Natural Product Research, 25, 890-897;
18. (b) Banskota AH, Tezuka Y, Tran KQ, Tanaka K, Saiki I, Kadota S. (1999) Thirteen novel cycloartane-type triterpenes from Combretum quadrangulare. Journal of Natural Products, 63, 57-64.
19. (a) Fotie J, Bohle DS, Leimanis ML, Georges E, Rukunga G, Nkengfack AE. (2006) Lupeol long-chain fatty acid esters with antimalarial activity from Holarrhena floribunda. Journal of Natural Products, 69, 62-67;
20. (b) Ragasa CY, de-Luna RD, Hofilena JG. (2005) Antimicrobial terpenoids from Pterocarpus indicus. Natural Product Research, 19, 305-309;
21. (c) You YJ, Nam NH, Kim Y, Bae KH, Ahn BZ. (2003) Antiangiogenic activity of lupeol from Bombax ceiba. Phytotherapy Research, 17, 341-344.
22. Agarwal RB, Rangari VD. (2003) Antiinflammatory and antiarthritic activities of lupeol and 19α-H lupeol isolated from Strobilanthus callosus and Strobilanthus ixiocephala roots. Indian Journal of Pharmacology, 35, 384-387.
23. Chandramu C, Manohar RD, Krupadanam DG, Dashavantha RV. (2003) Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L. Phytotherapy Research, 17, 129-134.
24. Fulda S. (2008) Betulinic acid for cancer treatment and prevention. International Journal of Molecular Science, 9, 1096-1107.
25. Mann A, Ibrahim K, Oyewale AO, Amupitan JO, Fatope MO, Okogun JI. (2011) Antimycobacterial friedelane-terpenoid from the root bark of Terminalia avicennioides. American Journal of Chemistry, 1, 52-55.
26. Antonisamy P, Duraipandiyan V, Ignacimuthu S. (2011) Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models. The Journal of Pharmacy and Pharmacology, 63, 1070-1077.
27. (a) Ringbom T, Huss U, Stenholm A, Flock S, Skatteboel P, Perera P, Bohlin L. (2001) COX-2-inhibitory effects on naturally occurring and modified fatty acids. Journal of Natural Products, 64, 745-749;
28. (b) Kim JY, Park HD, Park E, Chon JW, Park YK. (2009) Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Annals of the New York Academy of Sciences, 1171, 190-195.
29. (a) Ahmad A, Khan A, Manzoor N, Khan LA. (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microbial Pathogenesis, 48, 35-41;
30. (b) CLSI/NCCLS. (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-3rd Edition. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
31. (a) Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. (1999) Quantitation of ergosterol content: Novel method for determination of fluconazole susceptibility of Candida albicans. Journal of Clinical Microbiology, 37, 3332-3337;
32. (b) Breivik ON, Owades JL. (1957) Spectrophotometric semi-micro determination of ergosterol in yeast. Journal of Agriculture and Food Chemistry, 5, 360-363.